DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating
NCT02487550
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
1200
Enrollment
OTHER
Sponsor class
Conditions
Renal Neoplasma
Interventions
BIOLOGICAL:
DC-CIK
BIOLOGICAL:
IL-2/IFN-α
Sponsor
The First People's Hospital of Changzhou